MEXICAN BIOSIMILAR FILGRASTIM FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL MOBILIZATION AND TRANSPLANTATION

被引：0
|
作者：
Leon-Gonzalez, Monica [1 ,2 ]
Leon-Pena, Andres A. [1 ,3 ]
Fernanda Vallejo-Villalobos, Maria [2 ,4 ]
Karen Nunez-Cortes, Ana [1 ,3 ]
Ruiz-Arguelles, Alejandro [4 ,5 ]
Ruiz-Arguelles, Guillermo J. [1 ,2 ,4 ,5 ]
机构：
[1] Ctr Hematol & Med Interna Puebla, Clin Ruiz, Puebla, Mexico
[2] Univ Popular Autonoma Estado Puebla, Puebla, Mexico
[3] Benemerita Univ Autonoma Puebla, Puebla, Mexico
[4] Labs Clin Puebla, Puebla, Mexico
[5] Univ Americas Puebla, Cholula, Mexico
来源：
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | 2016年 / 68卷 / 04期
关键词：
Biosimilar; Filgrastim; G-CSF; HSCT; COLONY-STIMULATING FACTOR; G-CSF; EFFICACY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background: Following the release of the initial presentation of filgrastim (granulocyte colony-stimulating factor), several biosimilars have been developed worldwide. Objective: To study the efficacy of a Mexican biosimilar granulocyte colony-stimulating factor in a single transplant center. Methods: In a group of 19 consecutive patients with multiple sclerosis given autografts, we employed granulocyte colony-stimulating factors to mobilize stem cells from the bone marrow to the peripheral blood, either the original granulocyte colony-stimulating factor (n = 10) or a Mexican granulocyte colony-stimulating factor biosimilar (n = 9). Results: The efficacy of both agents was similar in mobilization capacity, white blood cell count rise, stem cell collection, and kinetics of auto-engraftment. Conclusion: We conclude that both granulocyte colony-stimulating factor agents were similar in their efficacy to mobilize stem cells and usefulness in autografts.
引用
收藏
页码：181 / 183
页数：3
相关论文
共 50 条
  • [1] Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation
    Shahzad, Moazzam
    Amin, Muhammad Kashif
    Bellman, Polina
    Al-Ramahi, Joe
    Noor, Jawad
    Vyas, Abhinav
    Mahmoudjafari, Zahra
    Mcguirk, Matthew
    Dejarnette, Shaun
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Shune, Leyla
    Singh, Anurag K.
    McGuirk, Joseph P.
    Abhyankar, Sunil
    Mushtaq, Muhammad Umair
    [J]. TRANSFUSION, 2024, 64 (08) : 1402 - 1406
  • [2] COMPARATIVE ANALYSIS OF FILGRASTIM, BIOSIMILAR FILGRASTIM AND LENOGRASTIM AS PERIPHERAL BLOOD CD34+MOBILIZATION DRUG FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Soria, B.
    Ubierna, P.
    Rodriguez-Lopez, J.
    Iglesias, A.
    Mesa, J.
    Gonzalez-Perera, I.
    Gonzalez-de-la-Fuente, G.
    Hernandez-Garcia, M. T.
    Raya, J. M.
    [J]. HAEMATOLOGICA, 2015, 100 : 793 - 794
  • [3] EFFICACY AND SAFETY OF FILGRASTIM BIOSIMILAR COMPARED TO FILGRASTIM ORIGINATOR IN THE STEM CELL MOBILIZATION AND HEMATOPOIETIC ENGRAFTMENT IN PATIENTS UNDERGOING STEM CELL TRANSPLANTATION
    Lopez-Parra, M.
    Baile, M.
    Davila, J.
    Caballero, J. C.
    Veiga, A.
    Arratibel, N.
    Lopez-Cadenas, F.
    Garcia-Martin, L.
    Salinero, M.
    Gutierrez, N. C.
    Lopez-Villar, O.
    Caballero, M. D.
    Garcia-Sanz, R.
    [J]. HAEMATOLOGICA, 2017, 102 : 628 - 629
  • [4] Comparison of Biosimilar Filgrastim (Nivestym) Versus Originator Filgrastim (Neupogen) for Peripheral Blood Stem Cell Mobilization for Allogeneic Hematopoietic Stem Cell Transplantation
    Shahzad, Moazzam
    Al-Ramahi, Joe S.
    Amin, Muhammad Kashif
    Khalid, Muhammad Fareed
    DeJarnette, Shaun
    Mahmoudjafari, Zahra
    Nelson, Maggie
    Hastings, Riley
    Abdelhakim, Haitham
    Lutfi, Forat
    Ahmed, Nausheen
    Bansal, Rajat
    Shune, Leyla
    Abdallah, Al-Ola
    Singh, Anurag K.
    Abhyankar, Sunil
    McGuirk, Joseph P.
    Mushtaq, Muhammad Umair
    [J]. BLOOD, 2023, 142
  • [5] USE OF BIOSIMILAR FILGRASTIM FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION IN AUTOLOGOUS TRANSPLANTATION: AN ANALYSIS OF EFFICACY AND SAFETY
    Gerivaz, R.
    Schuh, J.
    Costa, F.
    Ferreira, G.
    Botelho de Sousa, A.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S220 - S220
  • [6] Biosimilar Filgrastim in Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization and Post-Transplant Hematologic Recovery
    Marchesi, Francesco
    Mengarelli, Andrea
    [J]. CURRENT MEDICINAL CHEMISTRY, 2016, 23 (21) : 2217 - 2229
  • [7] Innovator Filgrastim versus Generic Filgrastim in Hematopoietic Stem Cell Transplantation Mobilization
    Husian, Sadik
    Jeyaraman, Preethi
    Gupta, S. K.
    Rai, Reeta
    Pathak, Sangeeta
    Dayal, Nitin
    Naithani, Rahul
    [J]. SOUTH ASIAN JOURNAL OF CANCER, 2021, 10 (03) : 172 - 174
  • [8] Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation
    Pham, Tina
    Patil, Sushrut
    Fleming, Shaun
    Avery, Sharon
    Walker, Patricia
    Wei, Andrew
    Curtis, David
    Stuart, Georgia
    Klarica, Daniela
    O'Brien, Maureen
    Morris, Karen
    Das, Tongted
    Bollard, Geraldine
    Muirhead, Jennifer
    Coutsouvelis, John
    Spencer, Andrew
    [J]. TRANSFUSION, 2015, 55 (11) : 2709 - 2713
  • [9] Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma
    Lisenko, Katharina
    Baertsch, Marc-Andrea
    Meiser, Renate
    Pavel, Petra
    Bruckner, Thomas
    Kriegsmann, Mark
    Schmitt, Anita
    Witzens-Harig, Mathias
    Ho, Anthony D.
    Hillengass, Jens
    Wuchter, Patrick
    [J]. TRANSFUSION, 2017, 57 (10) : 2359 - 2365
  • [10] Pegylated Filgrastim Is Comparable with Filgrastim As Support for Autologous Hematopoietic Stem Cell Transplantation
    Manuel Herrera, Juan
    Fernando Huertas, Jose
    Angel Saavedra, Miguel
    Gomez, Rigoberto
    Jose Guerrero, Alvaro
    Enrique Duque, Jorge
    Marcela Urrego, Olga
    Del Pilar Salcedo, Rocio
    Martinez, Alexander
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S112 - S112
12345